Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionOstrum Asset Management
Latest Disclosed Ownership4,263 shares
Latest Disclosed Value $ 1,499,937
Ostrum Asset Management reports 43.97% decrease in ownership of AMGN / Amgen Inc.

On May 14, 2026 - Ostrum Asset Management filed a 13F-HR form disclosing ownership of 4,263 shares of Amgen Inc. (MX:AMGN) valued at $1,499,937 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 7,608 shares of Amgen Inc.. This represents a change in shares of -43.97% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMGEN Common Stock 031162100 4,263 -3,345 -43.97 1,500 -39.80 0.0842
2026-02-13 2025-12-31 13F AMGEN Common Stock 031162100 7,608 -4,451 -36.91 2,490 -26.83 0.1195
2025-11-14 2025-09-30 13F AMGEN Common Stock 031162100 12,059 -348 -2.80 3,403 -1.76 0.1529
2025-08-13 2025-06-30 13F AMGEN Common Stock 031162100 12,407 437 3.65 3,464 -7.11 0.1623
2025-05-14 2025-03-31 13F AMGEN Common Stock 031162100 11,970 -243 -1.99 3,729 17.15 0.1963
2025-02-13 2024-12-31 13F AMGEN Common Stock 031162100 12,213 -587 -4.59 3,183 -22.82 0.2757
2024-11-13 2024-09-30 13F AMGEN Common Stock 031162100 12,800 -3,685 -22.35 4,124 -19.92 0.3413
2024-08-13 2024-06-30 13F AMGEN Common Stock 031162100 16,485 -430 -2.54 5,151 7.09 0.4492
2024-05-13 2024-03-31 13F AMGEN Common Stock 031162100 16,915 -3,085 -15.43 4,809 -16.51 0.3801
2024-02-13 2023-12-31 13F AMGEN Common Stock 031162100 20,000 -5,931 -22.87 5,760 -17.35 0.5007
2023-11-14 2023-09-30 13F AMGEN Common Stock 031162100 25,931 -384 -1.46 6,969 19.29 0.6449
2023-08-11 2023-06-30 13F AMGEN Common Stock 031162100 26,315 -291 -1.09 5,842 -9.17 0.4897
2023-05-12 2023-03-31 13F AMGEN Common Stock 031162100 26,606 26,606 6,432 0.5603
2019-11-13 2019-09-30 13F AMGEN Common Stock 031162100 0 -5,230 -100.00 0 -100.00
2019-08-13 2019-06-30 13F AMGEN Common Stock 031162100 5,230 -1,241 -19.18 964 -21.56 0.2671
2019-05-15 2019-03-31 13F AMGEN Common Stock 031162100 6,471 0 0.00 1,229 -2.46 0.4027
2019-02-14 2018-12-31 13F AMGEN Common Stock 031162100 6,471 6,471 1,260 0.4945
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.